首页> 美国卫生研究院文献>Journal of Clinical Microbiology >AmpC Disk Test for Detection of Plasmid-Mediated AmpC β-Lactamases in Enterobacteriaceae Lacking Chromosomal AmpC β-Lactamases
【2h】

AmpC Disk Test for Detection of Plasmid-Mediated AmpC β-Lactamases in Enterobacteriaceae Lacking Chromosomal AmpC β-Lactamases

机译:AmpC磁盘测试用于检测缺乏染色体AmpCβ-内酰胺酶的肠杆菌科细菌中的质粒介导的AmpCβ-内酰胺酶

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although plasmid-mediated AmpC β-lactamases were first reported in the late 1980s, many infectious disease personnel remain unaware of their clinical importance. These enzymes are typically produced by isolates of Escherichia coli, Klebsiella spp., Proteus mirabilis, and Salmonella spp. and are associated with multiple antibiotic resistance that leaves few therapeutic options. Plasmid-mediated AmpC β-lactamases have been associated with false in vitro susceptibility to cephalosporins. Many laboratories do not test for this resistance mechanism because current tests are inconvenient, subjective, lack sensitivity and/or specificity, or require reagents that are not readily available. In this study a new test, the AmpC disk test, based on filter paper disks impregnated with EDTA, was found to be a highly sensitive, specific, and convenient means of detection of plasmid-mediated AmpC β-lactamases in organisms lacking a chromosomally mediated AmpC β-lactamase. Using cefoxitin insusceptibility as a screen, the test accurately distinguished AmpC and extended-spectrum β-lactamase production and differentiated AmpCs from non-β-lactamase mechanisms of cefoxitin insusceptibility, such as reduced outer membrane permeability. The test is a potentially useful diagnostic tool. It can provide important infection control information and help to ensure that infected patients receive appropriate antibiotic therapy.
机译:尽管质粒介导的AmpCβ-内酰胺酶是在1980年代后期首次报道的,但许多传染病人员仍未意识到其临床重要性。这些酶通常由大肠杆菌,克雷伯菌属,奇异变形杆菌和沙门氏菌的分离物产生。并且与多种抗生素耐药性相关,因此几乎没有治疗选择。质粒介导的AmpCβ-内酰胺酶与体外对头孢菌素的错误敏感性有关。许多实验室不测试这种耐药性机制,因为当前的测试不方便,主观,缺乏敏感性和/或特异性,或者需要的试剂不易获得。在这项研究中,发现一种新的测试,即AmpC圆盘测试,基于浸有EDTA的滤纸圆盘,是检测缺乏染色体介导的生物体中质粒介导的AmpCβ-内酰胺酶的一种高度灵敏,特异性和便捷的方法。 AmpCβ-内酰胺酶。该测试使用头孢西丁不敏感性作为筛查,可准确地区分AmpC和广谱β-内酰胺酶的产生,并将AmpCs与头孢西丁不敏感性的非β-内酰胺酶机制区分开,例如降低的外膜通透性。该测试是潜在有用的诊断工具。它可以提供重要的感染控制信息,并有助于确保感染的患者接受适当的抗生素治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号